文献速递帕金森病与运动障碍认知障碍与痴呆

帕金森病中的多巴胺能视网膜细胞丢失与视觉功能障碍

Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease.
PubMed 文献 · Ann Neurol · 2020-09-19

该研究利用免疫组化和共聚焦显微镜评估帕金森病患者与对照供体视网膜中多巴胺能无长突细胞及其突触后细胞(AII无长突细胞和含黑视素视网膜神经节细胞)的形态、数量和突触连接。结果显示帕金森病中多巴胺能无长突细胞数量在不同视网膜区域减少26%至58%,与AII细胞和黑视素细胞的突触接触分别下降60%和35%;AII细胞数量未减但出现线粒体丢失和连接蛋白36丢失。作者认为多巴胺系统损害和杆细胞通路受累可能部分解释帕金森病患者的对比敏感度下降、视网膜电图异常及昼夜节律和睡眠障碍,支持视网膜反映脑神经退行性变并参与帕金森病病理。

要点

  • 帕金森病视网膜多巴胺能无长突细胞数量减少26%–58%,与AII细胞突触接触减少60%。
  • AII细胞数量未减但线粒体丢失和连接蛋白36丢失,提示能量衰竭和杆细胞通路信号传递异常。
  • 视网膜多巴胺能损害可能参与帕金森病对比敏感度下降、昼夜节律和睡眠障碍。

核心结论

  • 帕金森病视网膜多巴胺能系统受损及AII细胞介导的杆细胞通路受累,可能部分解释视觉和昼夜节律异常。
  • 视网膜重现脑神经退行性变并高度参与帕金森病病理。

研究设计与样本

  • 使用免疫组化和共聚焦显微镜评估帕金森病与对照人供体视网膜中多巴胺能无长突细胞及其突触后细胞的形态、数量和突触连接。

主要发现

  • 帕金森病中多巴胺能无长突细胞数量在不同视网膜区域减少58%至26%。
  • 多巴胺能无长突细胞与AII无长突细胞的突触接触减少60%,与黑视素细胞的突触接触减少35%。
  • AII细胞数量未减少,但其小叶附属物内线粒体丢失,且连接蛋白36丢失。

临床怎么用

  • 视网膜多巴胺能细胞和AII细胞改变可作为帕金森病视觉及昼夜节律障碍的病理基础,支持视网膜作为观察帕金森病神经退行性变的窗口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Considering the demonstrated implication of the retina in Parkinson disease (PD) pathology and the importance of dopaminergic cells in this tissue, we aimed to analyze the state of the dopaminergic amacrine cells and some of their main postsynaptic neurons in the retina of PD. METHODS: Using immunohistochemistry and confocal microscopy, we evaluated morphology, number, and synaptic connections of dopaminergic cells and their postsynaptic cells, AII amacrine and melanopsin-containing retinal ganglion cells, in control and PD eyes from human donors. RESULTS: In PD, dopaminergic amacrine cell number was reduced between 58% and 26% in different retinal regions, involving a decline in the number of synaptic contacts with AII amacrine cells (by 60%) and melanopsin cells (by 35%). Despite losing their main synaptic input, AII cells were not reduced in number, but they showed cellular alterations compromising their adequate function: (1) a loss of mitochondria inside their lobular appendages, which may indicate an energetic failure; and (2) a loss of connexin 36, suggesting alterations in the AII coupling and in visual signal transmission from the rod pathway. INTERPRETATION: The dopaminergic system impairment and the affection of the rod pathway through the AII cells may explain and be partially responsible for the reduced contrast sensitivity or electroretinographic response described in PD. Also, dopamine reduction and the loss of synaptic contacts with melanopsin cells may contribute to the melanopsin retinal ganglion cell loss previously described and to the disturbances in circadian rhythm and sleep reported in PD patients. These data support the idea that the retina reproduces brain neurodegeneration and is highly involved in PD pathology. ANN NEUROL 2020;88:893-906.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Ortuño-Lizarán I, Sánchez-Sáez X, Lax P, et al. Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease. Ann Neurol. 2020. PMID: 32881029. doi:10.1002/ana.25897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。